Prescription-fiIling rates for key medications in Veterans Affairs patients after coronary artery bypass grafting

被引:10
作者
Huang, JV [1 ]
Casebeer, AW
Plomondon, ME
Shroyer, ALW
McDonald, GO
Fullerton, D
Bell, MR
Baltz, J
Grover, FL
Cunningham, F
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Gen Internal Med, Denver, CO 80309 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80309 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80309 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Denver, CO 80309 USA
[5] Cent Off, Washington, DC USA
[6] Univ Colorado, Hlth Sci Ctr, Div Cardiothorac Surg, Denver, CO 80309 USA
关键词
angiotensin antagonists; angiotensin-converting-enzyme inhibitors; antilipemic agents; aspirin; coronary artery bypass; Department of Veterans Affairs; drug use; platelet aggregation inhibitors; protocols; sympatholytic agents;
D O I
10.1093/ajhp/61.12.1248
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Purpose. The six-month prescription-filling rates for key secondary-prevention drugs in Department of Veterans Affairs (VA) patients who had undergone coronary artery bypass grafting (CABG) were studied. Methods. Patient records for elective CABG from April 2000 through March 2002 (divided into four six-month periods) were analyzed. The study population included 8925 CABG-only patients surviving to hospital discharge. For each six-month period and in aggregate, the primary study endpoint was the six-month prescription-filling rate. Results. Across the four six-month periods, prescription-filling rates increased for all categories of medications studied. There were modest progressive increases for lipid-lowering agents, statins, beta-blockers, angiotensin-converting-enzyme inhibitors, and angiotensin-receptor blockers. The antithrombotic-filling rate averaged 88.5%. Filling rates for aspirin were much higher than for aspirin alternatives. Conclusion. Prescription-filling rates for post-CABG medications in VA facilities were generally high and suggested compliance with guidelines for the prevention of cardiovascular events.
引用
收藏
页码:1248 / 1252
页数:5
相关论文
共 20 条
[1]
*AM HEART ASS, 2003, GET GUID NOT
[2]
*AM HEART ASS, 2003, HEART DIS STROK STAT
[3]
Are we negating the benefits of CABG by forgetting secondary prevention? [J].
Belcher, PR ;
Gaw, A ;
Cooper, M ;
Brown, M ;
Wheatley, DJ ;
Lindsay, GM .
JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (10) :691-697
[4]
A β-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery [J].
Bert, AA ;
Reinert, SE ;
Singh, AK .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (02) :204-209
[5]
ATHEROSCLEROSIS AFTER CORONARY-ARTERY BYPASS-SURGERY - RESULTS OF RECENT STUDIES AND RECOMMENDATIONS REGARDING PREVENTION [J].
BOURASSA, MG ;
CAMPEAU, L ;
LESPERANCE, J ;
SOLYMOSS, BC .
CARDIOLOGY, 1986, 73 (4-5) :259-268
[6]
LONG-TERM VEIN GRAFT PATENCY [J].
BOURASSA, MG .
CURRENT OPINION IN CARDIOLOGY, 1994, 9 (06) :685-691
[7]
Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release [J].
Brull, DJ ;
Sanders, J ;
Rumley, A ;
Lowe, GD ;
Humphries, SE ;
Montgomery, HE .
HEART, 2002, 87 (03) :252-255
[8]
Outpatient adherence to beta-blocker therapy after acute myocardial infarction [J].
Butler, J ;
Arbogast, PG ;
BeLue, R ;
Daugherty, J ;
Jain, MK ;
Ray, WA ;
Griffin, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (09) :1589-1595
[9]
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors - NHLBI post coronary artery bypass graft clinical trial [J].
Campeau, L ;
Hunninghake, DB ;
Knatterud, GL ;
White, CW ;
Domanski, M ;
Forman, SA ;
Forrester, JS ;
Geller, NL ;
Gobel, FL ;
Herd, JA ;
Hoogwerf, BJ ;
Rosenberg, Y .
CIRCULATION, 1999, 99 (25) :3241-3247
[10]
Coombs John H, 2002, Manag Care Interface, V15, P54